|Bid||62.51 x 1300|
|Ask||0.00 x 1800|
|Day's range||64.79 - 65.41|
|52-week range||53.02 - 85.00|
|Beta (5Y monthly)||1.17|
|PE ratio (TTM)||8.93|
|Earnings date||27 Jul 2021 - 02 Aug 2021|
|Forward dividend & yield||N/A (N/A)|
|1y target est||82.92|
Hologic's (HOLX) Aptima CMV Quant assay is intended to help in the diagnosis and management of solid-organ transplant patients and hematopoietic stem cell transplant patients.
Hologic (HOLX) closed at $64.47 in the latest trading session, marking a +0.7% move from the prior day.
MARLBOROUGH, Mass., June 23, 2021--Hologic Receives European CE Mark for Molecular Assay to Quantify Human Cytomegalovirus